INNOVATIVE RESEARCH & EDUCATION
The Institute for Biomedical Sciences is training future generations of leading biomedical scientists and professionals through a unique approach to education that highlights the connection among science, business and law and teaches sought-after, technical skills in our advanced labs. Our world-class researchers are tackling some of the most urgent human diseases such as COVID-19, developing new vaccines, diagnostics and therapeutics in research centers focused on microbial pathogenesis, translational immunology and inflammation, immunity and infection.
Breakthroughs in Georgia: Enterprising Biomedicine
In a very short time, Georgia State University has built an impressive research enterprise. It’s the Institute for Biomedical Sciences, and its scientists are unlocking new insights and answers to an array of diseases and ailments. Tens of millions of dollars in research grants flow into the institute each year, and the university is planning even more expansion.
Explore Our Programs
Biomedical Science Research
STOPPING A GLOBAL KILLER
FIGHTING DISEASE THREATS
While humans have encountered some deadly viruses over the centuries such as influenza, Ebola, smallpox, SARS, MERS and HIV, there are inevitably new, life-threatening diseases out there waiting to emerge. Experts have agreed that it wasn’t a question of if – but when – another lethal infectious agent would occur and speculated if the world would be ready to fight it. Sadly, the answer is no.
News Stories & Events
More
Top Stories
Georgia State University Alumni Association Announces 40 Under 40 Class of 2022
The 40 Under 40 program honors, recognizes and celebrates the most influential and impactful Georgia State graduates under the age of 40 who embody the values of the university.read more ❯
The Business of Science
A new course offered in the Biomedical Enterprise master’s program in the Institute for Biomedical Sciences teaches students about scientific commercialization.read more ❯
Biomedical Sciences Expert on Using Nanotechnology to Treat IBD and Colorectal Cancer Available for Interviews
Dr. Didier Merlin, a Distinguished University Professor in the Institute for Biomedical Sciences at Georgia State University and a Senior Research Career Scientist at VA Medical Center, is available to discuss his research on developing new drug delivery platforms to treat intestinal bowel disease (IBD) and colorectal cancer using nanotechnology approaches. read more ❯